Skip to main content
OpenTrials
Completed

NCT Number: NCT02724657

Buteyko Method for Asthmatic Children With Mouth Breathing

To assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of asthmatic children with mouth breathing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Mouth Breathing Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Hypersensitivity Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory

Age range

7 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidade Federal do Rio Grande do Norte (UFRN)

Natal, Rio Grande do Norte, 59078970, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children from 7 up to 12 years old with asthma diagnose
  • Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks.
  • Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, and tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.

Exclusion criteria

  • Children that are not able to perform some of the necessary procedures, give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Treatment and study plan

Buteyko Method

Other

Intervention will be held twice a week during 3 weeks.

Primary outcomes

  1. Change in Sleep disturbance (questionnaire)

    Time frame: Baseline, three weeks later and six months after treatment

    Sleep disturbance will be assessed by the sleep disturbance scale for children (SDSC).

Secondary outcomes

  1. Change in spirometry (FVC, FEV1, FEV1/FVC, FEF25-75%, PEF)

    Time frame: Baseline, three weeks later and six months after treatment

  2. Change in ventilometry (minute volume and vital capacity)

    Time frame: Baseline, three weeks later and six months after treatment

    Minute volume and vital capacity (liters)

  3. Number of hospitalizations

    Time frame: Through study completion, an average of three weeks and six months after treatment

  4. Number of days off-school

    Time frame: During the three weeks of treatment

Sponsors and collaborators

Lead sponsor

Universidade Federal do Rio Grande do Norte

Other

Registry information

Official study title

THE EFFECTS OF THE BUTEYKO METHOD IN MOUTH BREATHING ASTHMATIC CHILDREN: A CONTROLLED RANDOMIZED STUDY

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Mar 31, 2016
Registry last updated
Jan 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.